Assuming outcomes is required, the following results were found.

  • CMSC INforMS: Use of DMTs Changing ‘Natural History’ of Relapsing MS, Study Says

    the introduction of disease-modifying treatments (DMTs) some 20 years ago, according to a retrospective study. The study, “Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years,” was published in the...

    https://mschristian.org/index.php/blog/cmsc-informs-use-of-dmts-changing-natural-history-of-relapsing-ms-study-says
  • Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

    Serum neurofilament light chain level was associated with brain fraction loss, whereas this was less the case for clinical outcomes such as relapses or EDSS worsening. Meaning The association of serum neurofilament light chain level with changes in...

    https://mschristian.org/index.php/blog/association-between-serum-neurofilament-light-chain-levels-and-long-term-disease-course-among-patients-with-multiple-sclerosis-followed-up-for-12-years
  • Study shows importance of personal social networks on neurological outcomes

    "We find that there's a strong relationship between the health habits of people in a patient's social network and outcomes that are of interest to physicians who specialize in multiple sclerosis. This relationship must not be ignored when considering an...

    https://mschristian.org/index.php/articles/2-uncategorised/4481-study-shows-importance-of-personal-social-networks-on-neurological-outcomes
  • Sanofi and Happify Health solidify collaboration around prescription DTx designed to address mental health in people with MS

    evidence-based mental health digital therapeutics, to develop and study an app to help manage and improve psychological outcomes in people with MS. Digital therapeutics (DTx) deliver to patients evidence-based therapeutic interventions to patients that...

    https://mschristian.org/index.php/blog/sanofi-and-happify-health-solidify-collaboration-around-prescription-dtx-designed-to-address-mental-health-in-people-with-ms
  • CMSC INforMS: Use of DMTs Changing ‘Natural History’ of Relapsing MS, Study Says

    the introduction of disease-modifying treatments (DMTs) some 20 years ago, according to a retrospective study. The study, “Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years,” was published in the...

    https://mschristian.org/index.php/articles/2-uncategorised/9867-cmsc-informs-use-of-dmts-changing-natural-history-of-relapsing-ms-study-says
  • Hopes for Novel Stroke Drug Dashed in Trial

    LOS ANGELES -- A putative neuroprotective agent failed to improve stroke patients' outcomes when given in conjunction with endovascular thrombectomy in the ESCAPE-NA1 trial, although those not given a thrombolytic did appear to benefit. Nerinetide led...

    https://mschristian.org/index.php/blog/hopes-for-novel-stroke-drug-dashed-in-trial
  • Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

    Serum neurofilament light chain level was associated with brain fraction loss, whereas this was less the case for clinical outcomes such as relapses or EDSS worsening. Meaning The association of serum neurofilament light chain level with changes in...

    https://mschristian.org/index.php/articles/2-uncategorised/8866-association-between-serum-neurofilament-light-chain-levels-and-long-term-disease-course-among-patients-with-multiple-sclerosis-followed-up-for-12-years
  • Study shows importance of personal social networks on neurological outcomes

    "We find that there's a strong relationship between the health habits of people in a patient's social network and outcomes that are of interest to physicians who specialize in multiple sclerosis. This relationship must not be ignored when considering an...

    https://mschristian.org/index.php/blog/study-shows-importance-of-personal-social-networks-on-neurological-outcomes
  • Plant Based Diet study shows NO significant improvement on brain MRI, relapse rate or disability as assessed by EDSS scores in subjects with RRMS over one year

    (Diet) on brain MRI, clinical [MS relapses and disability, body mass index (BMI)] and metabolic (blood lipids and insulin) outcomes, QOL [Short Form-36 (SF-36)], and fatigue [Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS)], in...

    https://mschristian.org/index.php/blog/plant-based-diet-study-shows-no-significant-improvement-on-brain-mri-relapse-rate-or-disability-as-assessed-by-edss-scores-in-subjects-with-rrms-over-one-year
  • Disability in multiple sclerosis A reference for patients and clinicians

    Abstract Objective: To create a reference table of disability outcomes in multiple sclerosis (MS) that would enable patients to rank their disability relative to others' with similar disease duration and to develop a cost-effective research tool for...

    https://mschristian.org/index.php/blog/disability-in-multiple-sclerosis-a-reference-for-patients-and-clinicians
  • Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen - P&T Community

    Oncology. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is on revolutionizing clinical and outcomes research to accelerate the insights...

    https://mschristian.org/index.php/blog/concerto-healthai-establishes-real-world-data-and-ai-collaboration-with-janssen-p-t-community
  • Study: Transcarotid Stenting Has a Leg Up Over Femoral Approach

    A technique developed to reduce stroke risk in carotid artery stenting was associated with better outcomes compared to the conventional transfemoral approach to the carotids, a study showed. By avoiding the aortic arch with direct common carotid access...

    https://mschristian.org/index.php/blog/study-transcarotid-stenting-has-a-leg-up-over-femoral-approach
  • Alcohol Consumption Linked to Lower MS Disability

    Sclerosis (CLIMB) study. Drinking habits were also assessed, and influence of alcohol or wine consumption on clinical outcomes was assessed using regression models for relapse rate in the past year, and concurrent EDSS and MSSS outcomes. Associations...

    https://mschristian.org/index.php/blog/alcohol-consumption-linked-to-lower-ms-disability
  • Capsule Technologies Launches Next Generation Clinical Computing Hub - P&T Community

    the evolving challenges providers face in managing complex device integration at the point of care and ensure quality outcomes for their patients," said Hemant Goel, CEO of Capsule Technologies. "Our clients are looking for more than just basic medical...

    https://mschristian.org/index.php/blog/capsule-technologies-launches-next-generation-clinical-computing-hub-p-t-community
  • Johns Hopkins researchers identify new way to lower blood pressure in obese patients

    mice, the researchers reported recently in the journal Circulation Research. Obesity leads to a lot of bad cardiovascular outcomes, and a significant portion of those are related to poorly controlled blood pressure. We've identified what may be a new...

    https://mschristian.org/index.php/blog/johns-hopkins-researchers-identify-new-way-to-lower-blood-pressure-in-obese-patients
  • #ECTRIMS2019 – Tysabri During Pregnancy and After Delivery Seems Safe, Reduces Relapse Risk, Study Finds

    then compared the annualized relapse rate (ARR) during pregnancy, and one year after delivery, as well as newborn outcomes, across groups. During pregnancy, there was a significantly higher relapse rate in the women with “wash-out” pregnancies — those...

    https://mschristian.org/index.php/blog/ectrims2019-tysabri-during-pregnancy-and-after-delivery-seems-safe-reduces-relapse-risk-study-finds
  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    that advance understanding of neurofilament light chain (NfL) levels as a potential biomarker for predicting disability outcomes. Additionally, longer-term data of more than six years to be presented continue to show consistent safety and efficacy...

    https://mschristian.org/index.php/blog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims
  • Disability in multiple sclerosis A reference for patients and clinicians

    Abstract Objective: To create a reference table of disability outcomes in multiple sclerosis (MS) that would enable patients to rank their disability relative to others' with similar disease duration and to develop a cost-effective research tool for...

    https://mschristian.org/index.php/articles/2-uncategorised/9969-disability-in-multiple-sclerosis-a-reference-for-patients-and-clinicians
  • Study: Transcarotid Stenting Has a Leg Up Over Femoral Approach

    A technique developed to reduce stroke risk in carotid artery stenting was associated with better outcomes compared to the conventional transfemoral approach to the carotids, a study showed. By avoiding the aortic arch with direct common carotid access...

    https://mschristian.org/index.php/articles/2-uncategorised/9613-study-transcarotid-stenting-has-a-leg-up-over-femoral-approach
  • Prescription digital therapeutics: reimagining disease treatment - STAT

    solutions (such as face-to-face cognitive behavioral therapy sessions) and can collect and quantify information about outcomes in real-world settings. By leveraging both of these features, developers can demonstrate to managed care providers the value...

    https://mschristian.org/index.php/blog/prescription-digital-therapeutics-reimagining-disease-treatment-stat

Results 1 - 20 of 95